Mohit Rawat appointed CEO, bringing deep biopharma leadership and a track record of driving innovations in drug discovery to commercial and transactional success; former CEO Robin Carr transitions to new CTO…Read More
You might also be interested in reading ALPS ETF Trust – RiverFront Dynamic US Dividend Advantage ETF declares monthly distribution of $0.0777.
